Now Offering Monoclonal Antibody Therapy, a Breakthrough COVID-19 Treatment Under Emergency Use Authorization by the FDA

By jsmith | January 27, 2021 | Comments Off on Now Offering Monoclonal Antibody Therapy, a Breakthrough COVID-19 Treatment Under Emergency Use Authorization by the FDA

Oklahoma ER & Hospital now offers monoclonal antibody therapy as an alternative COVID-19 treatment option for those who meet the criteria mentioned below. The infusion therapies offered, including Eli Lilly’s bamlanivimab, and the combination of casirivimab and imdevimab, are under Emergency Use Authorization (EUA) issued by the U.S. Food and Drug Admisinstration (FDA). Casirivimab and…

Read More

Oklahoma ER & Hospital Celebrates Highly Successful Second Year

By jsmith | January 11, 2021 | Comments Off on Oklahoma ER & Hospital Celebrates Highly Successful Second Year

Media Contact Makailyn Dillon Director of Marketing mdillon@okerhospital.com 405-251-2300 EDMOND, Okla. (Jan. 11, 2021) – Oklahoma ER & Hospital is celebrating its second anniversary on January 25. In the two years since opening, Oklahoma ER & Hospital’s hard-working staff has helped patients overcome countless health-related issues and obstacles, including the COVID-19 global pandemic. The CIHQ…

Read More